{
    "SPADE_N_14929": {
        "Sequence Information": {
            "Peptide Name": "Euryjanicin A",
            "Sequence": "WPISFVP",
            "Sequence Length": 7,
            "Biological Activity": [
                "Anti-Gram+",
                "Antiviral",
                "Antiparasitic",
                "Anticancer"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Prosuberites laughlini",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Euryjanicin A: a new cycloheptapeptide from the Caribbean marine sponge Prosuberites laughlini.",
                    "Pubmed ID": "20161148",
                    "Reference": "Tetrahedron Lett. 2009;50:4571-4574",
                    "Author": "Vicente J, Vera B, Rodríguez AD, Rodríguez-Escudero I, Raptis RG",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/20161148"
                },
                {
                    "Title": "Isolation and structural elucidation of euryjanicins B-D, proline-containing cycloheptapeptides from the Caribbean marine sponge Prosuberites laughlini.",
                    "Pubmed ID": "19743810",
                    "Reference": "J Nat Prod. 2009;72:1555-1562",
                    "Author": "Vera B, Vicente J, Rodríguez AD",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/19743810"
                }
            ],
            "Mass": 845.0,
            "PI": 5.53,
            "Net Charge": 0,
            "Hydrophobicity": 0.94,
            "Frequent Amino Acids": "PFI",
            "Absent Amino Acids": "ACDEGHKLMNOQRTUY",
            "Basic Residues": 0,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 3,
            "Polar Residues": 4,
            "Positive Residues": 0,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_N_14929",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_17059",
                    "Similarity": 1.0,
                    "Sequence": "WPISFVP"
                },
                {
                    "SPADE_ID": "SPADE_N_01838",
                    "Similarity": 1.0,
                    "Sequence": "FVPLLVSKLVCVVTKKC"
                },
                {
                    "SPADE_ID": "SPADE_N_01893",
                    "Similarity": 1.0,
                    "Sequence": "FVPIWM"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Human lung adenocarcinoma NCI-H522(70-80% Inhibition=10µM),Human melanoma LOX-IMVI(80-90% Inhibition=10µM),Human ovarian adenocarcinoma IGROV1(80-90% Inhibition=10µM),Human renal carcinoma UO-31(70-80% Inhibition=10µM),Plasmodium falciparum W2(no activity data),Mycobacterium tuberculosis(no activity data),Hepatitis B virus (HBV)(no activity data),HSV-1(no activity data),Human Influenza A Virus H5N1(no activity data),Human Influenza B Virus(no activity data),Respiratory syncytial virus (RSV)(no activity data),West Nile virus WNV(no activity data)"
        }
    }
}